Hyperglycemia Drives Glycemic Variability in Patients with Type 2 Diabetes (T2DM)

被引：1

|

作者：

Olawsky, Evan A.

Zhang, Yuan

Alvear, Alison C.

Eberly, Lynn E.

Chow, Lisa S.

机构：

来源：

DIABETES | 2020年 / 69卷

基金：

美国国家卫生研究院;

关键词：

D O I：

10.2337/db20-864-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

864-P

引用

收藏

页数：2

相关论文

共 50 条

[11] Prolonged hyperglycemia uncovers β-cell weakness in first degree relatives (FDR) of patients with type 2 diabetes (T2DM)
Boden, G
Chen, XH
Mozzoli, M
DIABETES, 1999, 48 : A69 - A69
[12] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
Haering, Hans-Ulrich
Merker, Ludwig
Seewaldt-Becker, Elke
Weimer, Marc
Meinicke, Thomas
Broedl, Uli C.
Woerle, Hans J.
DIABETES, 2013, 62 : A282 - A282
[13] Improvements in Glycemic Control are Associated With a Decline in the Severity of Depressive Symptoms in Patients With Type 2 Diabetes Mellitus (T2DM)
Dzida, Grzegorz J.
Karnieli, Eddy
Svendsen, Anne Louise
Hermanns, Norbert
DIABETES, 2013, 62 : A212 - A212
[14] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
Kovacs, Christopher
Seshiah, Veeraswamy
Swallow, Ros
Jones, Russell
Rattunde, Henning
Woerle, Hans J.
Broedl, Uli C.
DIABETES, 2013, 62 : A291 - A291
[15] Pioglitazone (PIO) improves glycemic control in drug-therapy naive patients with type 2 diabetes (T2DM)
Herz, M
Tan, M
Johns, D
Robertson, KE
Gonzalez, B
Reviriego, J
Grossman, L
DIABETES, 2002, 51 : A481 - A481
[16] Effects of Acute Hyperglycemia and Hyperinsulinemia on Endothelial Function and Atherothrombotic Balance in Type 2 Diabetes (T2DM)
Perkins, Jennifer
Joy, Nino
Richardson, Antoinette
Briscoe, Vanessa
Gilliam, Jesse
Tate, Donna
Davis, Stephen N.
DIABETES, 2010, 59 : A216 - A216
[17] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
Fonseca, Vivian
Dejager, Sylvie
Albrecht, Diego
Shirt, Lynda
Schweizer, Anja
DIABETES, 2006, 55 : A111 - A111
[18] Consideration of Comorbidities in Treatment Choice for Patients with Type 2 Diabetes (T2DM)
Ritchey, Mary E.
Engel, Samuel S.
Liu, Zhiwen
Ntabadde, Catherine
Senderak, Michael
Shankar, Ravi
Qiu, Ying
Radican, Larry
Rajpathak, Swapnil
Brodovicz, Kimberly G.
DIABETES, 2014, 63 : A636 - A636
[19] Adiponectin as a Predictor of T2dm in the Asymptomatic Offspring of Patients with Type 2 Diabetes
Anwar, Muhammad Jawad
Sajjad, Ayesha
Jawad, Madiha
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (04): : 1316 - 1317
[20] Patients with type 2 diabetes (T2DM) have defective hepatic autoregulation
Chen, XH
Iqbal, N
Boden, G
DIABETES, 1999, 48 : A295 - A295

← 1 2 3 4 5 →